NFKB1 and breast carcinoma: Moreover, IL-6 has been linked to Lin28/Let7 signalling, where NFKB-activated Lin28 inhibits Let7, leading to increased IL-6 levels and consequent NFKB activation, enforcing a positive feedback loop that contributes to the generation and maintenance of CSC-like populations in breast cancer [64].